Currently, there are 2.50B common shares owned by the public and among those 2.49B shares have been available to trade.
The company’s stock has a 5-day price change of 0.43% and 17.58% over the past three months. UL shares are trading 26.49% year to date (YTD), with the 12-month market performance up to 18.17% higher. It has a 12-month low price of $46.16 and touched a high of $62.65 over the same period. UL has an average intraday trading volume of 2.69 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.38%, 8.04%, and 20.18% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Unilever plc ADR (NYSE: UL) shares accounts for 10.11% of the company’s 2.50B shares outstanding.
It has a market capitalization of $152.79B and a beta (3y monthly) value of 0.47. The stock’s trailing 12-month PE ratio is 21.51, while the earnings-per-share (ttm) stands at $2.85. The company has a PEG of 4.14 and a Quick Ratio of 0.56 with the debt-to-equity ratio at 1.56. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.40% over the week and 1.14% over the month.
Analysts forecast that Unilever plc ADR (UL) will achieve an EPS of 0 for the current quarter, 0 for the next quarter and 3.29 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0 while analysts give the company a high EPS estimate of 0. Earnings per share for the fiscal year are expected to increase by 10.94%, and 8.44% over the next financial year. EPS should grow at an annualized rate of 5.20% over the next five years, compared to -7.51% over the past 5-year period.
Looking at the support for the UL, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on July 23, 2024, with the firm’s price target at $67. JP Morgan was of a view on May 23, 2024 that the stock is Overweight, while Morgan Stanley gave the stock Underweight rating on February 27, 2024, issuing a price target of $52- $48. Bernstein on their part issued Mkt Perform rating on December 11, 2023.
